ASCENSIA DIABETES CARE HOLDINGS AG

History

Year	Detail
2016	Ascensia was established in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings. It is headquartered in Basel, Switzerland.
2017	The company partnered with Insulet Corporation, a company specializing in tubeless insulin pump technology with its Omnipod Insulin Management System, to connect Contour Next One Bgms and Omnipod Dash Pdm to manage their diabetes, powered by remarkably accurate blood glucose readings.
2017	The company partnered with Voluntis to connect the Voluntis basal insulin management solution for people with Type 2 diabetes.
2019	Ascensia partnered with Zhejiang POCTech, Co., Ltd (POCTech), a developer and manufacturer of continuous glucose monitoring (CGM) systems, to develop and manufacture products with enhanced capabilities and features designed to meet the needs of people with diabetes.
2021	The company launched GlucoContro.online, a browser-based diabetes management and analytics platform that enables data-driven care for people using one of the meters in the Contour blood glucose monitoring portfolio.
2022	The company collaborated with Senseonics Holdings, Inc., a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, to expand patient access by providing In-Office and at-home insertion options for Eversense E3 Continuous Glucose Monitoring System (CGM).
2023	The company collaborated with SNAQ, an app-based solution provider that offers key insights into food and nutrition for people with diabetes (PWDs), to support mealtime decision-making for PWDs.